相关实验视频

Updated: May 26, 2025

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

Published on: September 1, 2015

通过阻断抑制性BDCA-2通路,BTK-抑制增强pDCs中的TLR-7介导的干扰素-α产生

Laura Ceglarek^1,2, Ramona Gerhards¹, Vinicius Boldrini¹

¹Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

European journal of immunology

|February 24, 2025

概括

布鲁顿的氨酸激酶抑制剂 (BTKi) 通过TLR-9阻止IFN-α的产生,但在pDC中不能阻止TLR-7. 通过阻断BDCA-2通路,BTKi通过TLR-7增强IFN-α,影响SLE和MS治疗.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

等离子体树突细胞 (pDCs) 是I型干扰素 (IFN-α) 的关键生产者.
布鲁顿的氨酸激酶 (BTK) 是B细胞和pDC中的关键信号分子.
BTK 抑制剂 (BTKi) 正在研究自身免疫性疾病,如系统性红斑狼 (SLE) 和多发性硬化症 (MS).

研究的目的:

研究BTK抑制 (BTKi) 对通过托尔类受体9 (TLR-9) 和TLR-7刺激的pDCs对IFN-α产生的差异性影响.
阐明BTKi对pDC功能的影响背后的机制,特别是关于BDCA-2通路.

主要方法:

在存在或缺少BTKi的情况下,pDCs被TLR-9和TLR-7激动剂刺激.
测量了IFN-α的产生.
评估了BDCA-2通路在BTKi影响中的作用.

主要成果:

BTKi完全阻止了由TLR-9刺激引起的IFN-α产生.
BTKi并没有阻断,而是增强了TLR-7刺激诱导的IFN-α产生.
这种增强是由抑制性BDCA-2通路的阻断介导的.

结论:

根据TLR刺激途径,BTKi对pDC IFN-α产生有不同的影响.
由于BDCA-2通路的抑制,BTKi通过TLR-7增强IFN-α,可能导致BTKi在SLE中的有效性有限.
这些发现对BTKi在正在进行的MS临床试验中的战略使用具有重要意义.

关键词:

在BTK-i中.在 TLR 信号系统中.多发性硬化症多发性硬化症在pDC中,pDCs是指pDCs.系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.

更多相关视频

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...